Marijuana Smoking in Patients With Leukemia

Area of Science:

• Pulmonology
• Oncology
• Toxicology

Background:

• Marijuana (cannabis) is a widely used substance globally, second only to tobacco for smoking.
• While recreational use is common, research on its pulmonary effects, especially in leukemia patients, is limited.
• Understanding cannabis's impact on lung health is crucial given its increasing prevalence.

Observation:

• This case series details two men with acute myeloid leukemia (AML) who developed miliary nodular lung patterns on CT scans.
• These lung abnormalities in AML patients were attributed to heavy marijuana smoking.
• Additionally, two patients with acute lymphocytic leukemia (ALL) with a history of marijuana use presented with lung opacities suggestive of mold infection.

Findings:

• Heavy cannabis smoking can lead to distinct pulmonary changes, such as miliary nodular patterns, in individuals with hematologic malignancies.
• Marijuana use in leukemia patients may increase susceptibility to opportunistic lung infections like mold infections.
• These findings underscore the potential for adverse pulmonary events associated with cannabis use in immunocompromised populations.

Implications:

• Clinicians should consider heavy marijuana use when evaluating pulmonary symptoms in leukemia patients.
• Further research is needed to elucidate the mechanisms linking cannabis smoking to specific lung pathologies in immunocompromised individuals.
• Awareness of these risks can aid in early diagnosis and management of lung complications in cancer patients using cannabis.